Research Summary
Chemotherapy-induced peripheral neuropathy (CIPN) treatment refers to various approaches aimed at managing and alleviating the symptoms of nerve damage caused by chemotherapy drugs. CIPN is a common side effect of certain chemotherapy medications, leading to tingling, numbness, pain, and weakness in the hands and feet. The treatment options for CIPN focus on symptom relief and improving the patient's quality of life. Medications such as pain relievers, antidepressants, and anticonvulsants may be prescribed to manage nerve pain. Physical therapy and occupational therapy can help improve muscle strength and function and teach patients strategies to cope with daily challenges. Additionally, lifestyle modifications, such as regular exercise, maintaining a healthy diet, and avoiding activities that worsen symptoms, may also be recommended. As CIPN can vary in severity and persistence, the treatment approach is tailored to each patient's individual needs and the specific chemotherapy drugs involved, aiming to minimize discomfort and maximize functionality during and after cancer treatment.
According to DIResearch's in-depth investigation and research, the global Chemotherapy Induced Peripheral Neuropathy Treatment market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Chemotherapy Induced Peripheral Neuropathy Treatment include Aptinyx Inc, Asahi Kasei Pharma Corp, Regenacy Pharmaceuticals, MAKScientific LLC, Metys Pharmaceuticals AG, Nemus Bioscience Inc, PledPharma, Sova Pharmaceuticals Inc, DermaXon LLC, Krenitsky Pharmaceuticals Inc, Kineta Inc, PeriphaGen, Apexian Pharma, WinSanTor etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Chemotherapy Induced Peripheral Neuropathy Treatment. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Chemotherapy Induced Peripheral Neuropathy Treatment market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Chemotherapy Induced Peripheral Neuropathy Treatment market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Chemotherapy Induced Peripheral Neuropathy Treatment industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Chemotherapy Induced Peripheral Neuropathy Treatment Include:
Aptinyx Inc
Asahi Kasei Pharma Corp
Regenacy Pharmaceuticals
MAKScientific LLC
Metys Pharmaceuticals AG
Nemus Bioscience Inc
PledPharma
Sova Pharmaceuticals Inc
DermaXon LLC
Krenitsky Pharmaceuticals Inc
Kineta Inc
PeriphaGen
Apexian Pharma
WinSanTor
Chemotherapy Induced Peripheral Neuropathy Treatment Product Segment Include:
Calcium Channel ??2-delta Ligands
Antidepressants
Opioids
Others
Chemotherapy Induced Peripheral Neuropathy Treatment Product Application Include:
Platinum Agents
Taxanes
Vinca Alkaloids
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Chemotherapy Induced Peripheral Neuropathy Treatment Industry PESTEL Analysis
Chapter 3: Global Chemotherapy Induced Peripheral Neuropathy Treatment Industry Porter's Five Forces Analysis
Chapter 4: Global Chemotherapy Induced Peripheral Neuropathy Treatment Major Regional Market Size and Forecast Analysis
Chapter 5: Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Chemotherapy Induced Peripheral Neuropathy Treatment Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Chemotherapy Induced Peripheral Neuropathy Treatment Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Chemotherapy Induced Peripheral Neuropathy Treatment Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Chemotherapy Induced Peripheral Neuropathy Treatment Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Chemotherapy Induced Peripheral Neuropathy Treatment Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Chemotherapy Induced Peripheral Neuropathy Treatment Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Chemotherapy Induced Peripheral Neuropathy Treatment Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Chemotherapy Induced Peripheral Neuropathy Treatment Market Overview 1.1 Product Definition and Statistical Scope 1.2 Chemotherapy Induced Peripheral Neuropathy Treatment Product by Type 1.2.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Calcium Channel ??2-delta Ligands 1.2.3 Antidepressants 1.2.4 Opioids 1.2.5 Others 1.3 Chemotherapy Induced Peripheral Neuropathy Treatment Product by Application 1.3.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Platinum Agents 1.3.3 Taxanes 1.3.4 Vinca Alkaloids 1.3.5 Others 1.4 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Revenue Analysis (2019-2030) 1.5 Chemotherapy Induced Peripheral Neuropathy Treatment Market Development Status and Trends 1.5.1 Chemotherapy Induced Peripheral Neuropathy Treatment Industry Development Status Analysis 1.5.2 Chemotherapy Induced Peripheral Neuropathy Treatment Industry Development Trends Analysis 2 Chemotherapy Induced Peripheral Neuropathy Treatment Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Chemotherapy Induced Peripheral Neuropathy Treatment Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Analysis by Regions 4.1 Chemotherapy Induced Peripheral Neuropathy Treatment Overall Market: 2023 VS 2024 VS 2030 4.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Revenue and Market Share by Region (2019-2024) 4.2.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Revenue Forecast by Region (2025-2030) 5 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Type and Application 5.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Type 5.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Application 6 North America 6.1 North America Chemotherapy Induced Peripheral Neuropathy Treatment Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Type 6.4 North America Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Application 6.5 North America Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Type 7.4 Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Application 7.5 Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Chemotherapy Induced Peripheral Neuropathy Treatment Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Type 8.4 China Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Chemotherapy Induced Peripheral Neuropathy Treatment Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Type 9.4 APAC (excl. China) Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Application 9.5 APAC (excl. China) Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Chemotherapy Induced Peripheral Neuropathy Treatment Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Type 10.4 Latin America Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Application 10.5 Latin America Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Type 11.4 Middle East & Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Application 11.5 Middle East & Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Revenue by Key Manufacturers (2020-2024) 12.2 Chemotherapy Induced Peripheral Neuropathy Treatment Competitive Landscape Analysis and Market Dynamic 12.2.1 Chemotherapy Induced Peripheral Neuropathy Treatment Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Aptinyx Inc 13.1.1 Aptinyx Inc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Aptinyx Inc Chemotherapy Induced Peripheral Neuropathy Treatment Product Portfolio 13.1.3 Aptinyx Inc Chemotherapy Induced Peripheral Neuropathy Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Asahi Kasei Pharma Corp 13.2.1 Asahi Kasei Pharma Corp Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Asahi Kasei Pharma Corp Chemotherapy Induced Peripheral Neuropathy Treatment Product Portfolio 13.2.3 Asahi Kasei Pharma Corp Chemotherapy Induced Peripheral Neuropathy Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Regenacy Pharmaceuticals 13.3.1 Regenacy Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Regenacy Pharmaceuticals Chemotherapy Induced Peripheral Neuropathy Treatment Product Portfolio 13.3.3 Regenacy Pharmaceuticals Chemotherapy Induced Peripheral Neuropathy Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 MAKScientific LLC 13.4.1 MAKScientific LLC Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 MAKScientific LLC Chemotherapy Induced Peripheral Neuropathy Treatment Product Portfolio 13.4.3 MAKScientific LLC Chemotherapy Induced Peripheral Neuropathy Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Metys Pharmaceuticals AG 13.5.1 Metys Pharmaceuticals AG Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Metys Pharmaceuticals AG Chemotherapy Induced Peripheral Neuropathy Treatment Product Portfolio 13.5.3 Metys Pharmaceuticals AG Chemotherapy Induced Peripheral Neuropathy Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Nemus Bioscience Inc 13.6.1 Nemus Bioscience Inc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Nemus Bioscience Inc Chemotherapy Induced Peripheral Neuropathy Treatment Product Portfolio 13.6.3 Nemus Bioscience Inc Chemotherapy Induced Peripheral Neuropathy Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 PledPharma 13.7.1 PledPharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 PledPharma Chemotherapy Induced Peripheral Neuropathy Treatment Product Portfolio 13.7.3 PledPharma Chemotherapy Induced Peripheral Neuropathy Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 Sova Pharmaceuticals Inc 13.8.1 Sova Pharmaceuticals Inc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Sova Pharmaceuticals Inc Chemotherapy Induced Peripheral Neuropathy Treatment Product Portfolio 13.8.3 Sova Pharmaceuticals Inc Chemotherapy Induced Peripheral Neuropathy Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.9 DermaXon LLC 13.9.1 DermaXon LLC Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 DermaXon LLC Chemotherapy Induced Peripheral Neuropathy Treatment Product Portfolio 13.9.3 DermaXon LLC Chemotherapy Induced Peripheral Neuropathy Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.10 Krenitsky Pharmaceuticals Inc 13.10.1 Krenitsky Pharmaceuticals Inc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 Krenitsky Pharmaceuticals Inc Chemotherapy Induced Peripheral Neuropathy Treatment Product Portfolio 13.10.3 Krenitsky Pharmaceuticals Inc Chemotherapy Induced Peripheral Neuropathy Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.11 Kineta Inc 13.11.1 Kineta Inc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 Kineta Inc Chemotherapy Induced Peripheral Neuropathy Treatment Product Portfolio 13.11.3 Kineta Inc Chemotherapy Induced Peripheral Neuropathy Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.12 PeriphaGen 13.12.1 PeriphaGen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.12.2 PeriphaGen Chemotherapy Induced Peripheral Neuropathy Treatment Product Portfolio 13.12.3 PeriphaGen Chemotherapy Induced Peripheral Neuropathy Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.13 Apexian Pharma 13.13.1 Apexian Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.13.2 Apexian Pharma Chemotherapy Induced Peripheral Neuropathy Treatment Product Portfolio 13.13.3 Apexian Pharma Chemotherapy Induced Peripheral Neuropathy Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.14 WinSanTor 13.14.1 WinSanTor Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.14.2 WinSanTor Chemotherapy Induced Peripheral Neuropathy Treatment Product Portfolio 13.14.3 WinSanTor Chemotherapy Induced Peripheral Neuropathy Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Chemotherapy Induced Peripheral Neuropathy Treatment Industry Chain Analysis 14.2 Chemotherapy Induced Peripheral Neuropathy Treatment Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Chemotherapy Induced Peripheral Neuropathy Treatment Typical Downstream Customers 14.4 Chemotherapy Induced Peripheral Neuropathy Treatment Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support